Vincenzo Sangiovanni Selected Research

Vincenzo Sangiovanni Research Topics

Disease

12	COVID-19 07/2023 - 10/2020
6	Fibrosis (Cirrhosis) 01/2021 - 08/2016
5	Infections 06/2023 - 03/2012
3	Hypertension (High Blood Pressure) 01/2021 - 09/2011
2	Disease Progression 07/2023 - 06/2022
2	Ascites 01/2021 - 01/2018
2	HIV Infections (HIV Infection) 01/2020 - 02/2009
2	Hepatitis 04/2018 - 11/2017
2	Liver Cirrhosis (Hepatic Cirrhosis) 04/2018 - 01/2018
2	Neoplasms (Cancer) 01/2015 - 09/2011
1	Chronic Renal Insufficiency 07/2023
1	Bacterial Infections (Bacterial Infection) 06/2023
1	Coinfection 06/2023
1	Superinfection 06/2023
1	Dementia (Dementias) 06/2022
1	Chronic Hepatitis C 05/2021
1	Chronic Disease (Chronic Diseases) 04/2021
1	Kidney Diseases (Kidney Disease) 01/2021
1	Body Weight (Weight, Body) 12/2020
1	Ovarian Neoplasms (Ovarian Cancer) 11/2017
1	Adenocarcinoma 11/2017
1	Persistent Infection 08/2016
1	Osteosarcoma (Osteogenic Sarcoma) 10/2015
1	Kaposi Sarcoma (Kaposi's Sarcoma) 01/2015
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2015
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 03/2012
1	Lipodystrophy 02/2009
1	Hepatocellular Carcinoma (Hepatoma) 11/2007

Drug/Important Bio-Agent (IBA)

3	AlbuminsIBA 01/2021 - 01/2018
3	Protease Inhibitors (Protease Inhibitor)IBA 01/2021 - 01/2015
3	Ribavirin (Virazole)FDA LinkGeneric 10/2018 - 08/2016
3	Tenofovir (Viread)FDA Link 04/2018 - 10/2015
3	InterferonsIBA 11/2017 - 01/2015
2	RNA (Ribonucleic Acid)IBA 01/2023 - 08/2016
2	Ritonavir (Norvir)FDA Link 01/2021 - 10/2018
2	C-Reactive ProteinIBA 01/2021 - 10/2020
2	Antiviral Agents (Antivirals)IBA 04/2018 - 01/2017
2	Darunavir (Prezista)FDA Link 11/2017 - 10/2015
2	abacavir (Ziagen)FDA Link 11/2017 - 10/2015
2	etravirine (TMC-125)FDA Link 11/2017 - 10/2015
2	efavirenz (Sustiva)FDA Link 11/2017 - 10/2015
2	Glucose (Dextrose)FDA LinkGeneric 03/2012 - 09/2011
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 07/2023
1	CreatinineIBA 07/2023
1	Anti-Bacterial Agents (Antibiotics)IBA 06/2023
1	ProcalcitoninIBA 06/2023
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2023
1	BNT162 VaccineIBA 01/2023
1	BilirubinIBA 06/2022
1	Transaminases (Aminotransferases)IBA 06/2022
1	glecaprevir and pibrentasvirIBA 05/2021
1	Oxygen (Dioxygen)IBA 04/2021
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2021
1	Serum AlbuminIBA 01/2021
1	cobicistat mixture with darunavirIBA 01/2021
1	Heparin (Liquaemin)FDA LinkGeneric 01/2021
1	Lopinavir FDA Link 01/2021
1	LDL CholesterolIBA 01/2020
1	paritaprevirIBA 10/2018
1	ombitasvirIBA 10/2018
1	dasabuvirIBA 10/2018
1	entecavir FDA Link 04/2018
1	Furosemide (Lasix)FDA LinkGeneric 01/2018
1	Human Serum Albumin FDA LinkGeneric 01/2018
1	NucleotidesIBA 11/2017
1	NucleosidesIBA 11/2017
1	Reverse Transcriptase InhibitorsIBA 11/2017
1	Anti-HIV Agents (AIDS Drugs)IBA 11/2017
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 11/2017
1	Inosine TriphosphataseIBA 01/2017
1	N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA 08/2016
1	telaprevirIBA 08/2016
1	GoldIBA 01/2015
1	Complementary DNA (cDNA)IBA 03/2012
1	LipidsIBA 03/2012
1	Triglycerides (Triacylglycerol)IBA 09/2011
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 09/2011
1	CholesterolIBA 09/2011
1	Alanine Transaminase (SGPT)IBA 09/2011
1	beta CateninIBA 02/2009
1	GadoliniumIBA 11/2007

Therapy/Procedure

7	Therapeutics 04/2021 - 02/2009
3	Highly Active Antiretroviral Therapy (HAART) 01/2015 - 02/2009
1	Length of Stay 06/2023
1	Art Therapy 01/2023
1	Patient Isolation 04/2021
1	Artificial Respiration (Mechanical Ventilation) 01/2021
1	Aftercare (After-Treatment) 12/2020